Company news
Illumina, Inc. news in 2022
Illumina, Inc.'s news releases, calls and decks from 2022, newest first.
Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP
December 13, 2022
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022
November 2, 2022
Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States
November 2, 2022
Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
November 1, 2022
Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration
October 24, 2022
Illumina To Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022
October 23, 2022
Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis
October 17, 2022
Illumina to Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022
October 16, 2022
Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery
October 10, 2022
Illumina to Announce Third Quarter 2022 Financial Results on Thursday, November 3, 2022
October 5, 2022
Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health
September 28, 2022
Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum
September 28, 2022
Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via Livestream
September 25, 2022
John Hancock becomes the first life insurance carrier to offer access to GRAIL's multi-cancer early detection test to customers
September 19, 2022
Illumina to Host Upcoming Investor Day
September 18, 2022
Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care
September 18, 2022
Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications
September 13, 2022
Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New Infrastructure
September 11, 2022
llumina Announces Opportunity to View Live Webcast of Illumina Genomics Forum Innovation Roadmap Session Followed by Investor Conference Call
September 7, 2022
Illumina Genomics Forum to Feature Diverse Lineup of Visionary Global Leaders
September 6, 2022
Illumina Intends to Appeal European Commission's Decision in GRAIL Deal
September 5, 2022
Administrative Law Judge Rules in Favor of Illumina in FTC Challenge of GRAIL Deal
August 31, 2022
Illumina Deepens Commitment to Customers in China with New Manufacturing Site
August 29, 2022
Illumina Genomics Forum to Feature Tennis Legend Chris Evert on the Role Genomics Played in her Cancer Fight
August 28, 2022
Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki
August 21, 2022
Minderoo Foundation and Illumina Commit $40M AUD to Apply Advanced Genomics to Marine Conservation
August 15, 2022
Illumina Genomics Forum to Feature American Cancer Society CEO Karen Knudsen on the Future of Cancer Genomics
August 14, 2022
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022
August 10, 2022
Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Access to Genomics
August 7, 2022
Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities
July 26, 2022
Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama
July 17, 2022
Illumina to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022
July 13, 2022
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
July 13, 2022
Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
June 27, 2022
Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
June 21, 2022
Joydeep Goswami appointed interim CFO; sam samad to depart Illumina
June 8, 2022
Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions
June 6, 2022
Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO
June 1, 2022
Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy
May 23, 2022
Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
May 17, 2022
Illumina Reports Financial Results for First Quarter of Fiscal Year 2022
May 4, 2022
Illumina and Deerfield Management partner to accelerate drug development
May 4, 2022
Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
April 24, 2022
Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
April 13, 2022
Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center
April 11, 2022
John Frank Joins Illumina as Chief Public Affairs Officer
April 10, 2022
Illumina Releases Annual Corporate Social Responsibility Report
April 6, 2022
Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
March 15, 2022
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
March 14, 2022
Illumina Welcomes Carissa Rollins as Chief Information Officer
March 13, 2022
Calls in 2022
Decks in 2022
- Technical Presentation (October 2022)
Technical · 93 slides · October 2022